| pubmed-article:8932843 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8932843 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
| pubmed-article:8932843 | lifeskim:mentions | umls-concept:C0870134 | lld:lifeskim |
| pubmed-article:8932843 | lifeskim:mentions | umls-concept:C0021756 | lld:lifeskim |
| pubmed-article:8932843 | lifeskim:mentions | umls-concept:C0332835 | lld:lifeskim |
| pubmed-article:8932843 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:8932843 | lifeskim:mentions | umls-concept:C0439859 | lld:lifeskim |
| pubmed-article:8932843 | lifeskim:mentions | umls-concept:C1515895 | lld:lifeskim |
| pubmed-article:8932843 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:8932843 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:8932843 | pubmed:dateCreated | 1997-2-25 | lld:pubmed |
| pubmed-article:8932843 | pubmed:abstractText | IL-2 therapy may be useful in situations with a low tumour burden, such as after autologous transplantation. However, conflicting reports about the deleterious effects of this cytokine on haemopoiesis have precluded its widespread use. To study IL-2 effects on haemopoietic transplant progenitors we established long-term cultures (Dexter-type) with cells from allogeneic marrow and marrow/peripheral blood cell infusates of autologous transplants with different concentrations of IL-2 (0-1000 IU/ml). Percentage of CD56+ cells was also determined in cultures. IL-2 induced an inhibitory effect on stroma and an increase in the percentage of CD56+ cells compared with controls. No deleterious effect either in the production of BFU-E or CFU-GM weekly or over the whole period of culture was observed. Our results suggest that IL-2 is able to induce an increase in CD56+ cells early after transplantation without a deleterious effect on long-term haemopoiesis. | lld:pubmed |
| pubmed-article:8932843 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8932843 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8932843 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8932843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8932843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8932843 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8932843 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:8932843 | pubmed:issn | 0268-3369 | lld:pubmed |
| pubmed-article:8932843 | pubmed:author | pubmed-author:OdriozolaJJ | lld:pubmed |
| pubmed-article:8932843 | pubmed:author | pubmed-author:ParraCC | lld:pubmed |
| pubmed-article:8932843 | pubmed:author | pubmed-author:RoldánEE | lld:pubmed |
| pubmed-article:8932843 | pubmed:author | pubmed-author:RamosPP | lld:pubmed |
| pubmed-article:8932843 | pubmed:author | pubmed-author:QuirogaRR | lld:pubmed |
| pubmed-article:8932843 | pubmed:author | pubmed-author:Pérez-OteyzaJ... | lld:pubmed |
| pubmed-article:8932843 | pubmed:author | pubmed-author:García-Laraña... | lld:pubmed |
| pubmed-article:8932843 | pubmed:author | pubmed-author:CerveróCC | lld:pubmed |
| pubmed-article:8932843 | pubmed:author | pubmed-author:López-Jiménez... | lld:pubmed |
| pubmed-article:8932843 | pubmed:author | pubmed-author:HeindrichsBB | lld:pubmed |
| pubmed-article:8932843 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8932843 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:8932843 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8932843 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8932843 | pubmed:pagination | 899-905 | lld:pubmed |
| pubmed-article:8932843 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8932843 | pubmed:meshHeading | pubmed-meshheading:8932843-... | lld:pubmed |
| pubmed-article:8932843 | pubmed:meshHeading | pubmed-meshheading:8932843-... | lld:pubmed |
| pubmed-article:8932843 | pubmed:meshHeading | pubmed-meshheading:8932843-... | lld:pubmed |
| pubmed-article:8932843 | pubmed:meshHeading | pubmed-meshheading:8932843-... | lld:pubmed |
| pubmed-article:8932843 | pubmed:meshHeading | pubmed-meshheading:8932843-... | lld:pubmed |
| pubmed-article:8932843 | pubmed:meshHeading | pubmed-meshheading:8932843-... | lld:pubmed |
| pubmed-article:8932843 | pubmed:meshHeading | pubmed-meshheading:8932843-... | lld:pubmed |
| pubmed-article:8932843 | pubmed:meshHeading | pubmed-meshheading:8932843-... | lld:pubmed |
| pubmed-article:8932843 | pubmed:meshHeading | pubmed-meshheading:8932843-... | lld:pubmed |
| pubmed-article:8932843 | pubmed:meshHeading | pubmed-meshheading:8932843-... | lld:pubmed |
| pubmed-article:8932843 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8932843 | pubmed:articleTitle | IL-2 effects on allogeneic and autologous transplant haemopoietic progenitors in long-term cultures. | lld:pubmed |
| pubmed-article:8932843 | pubmed:affiliation | Department of Haematology, Hospital Ramón y Cajal, Universidad de Alcalá de Henares, Madrid, Spain. | lld:pubmed |
| pubmed-article:8932843 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8932843 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
